|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 35/00 | (2018.01) |
| C07K 16/28 | (2006.01) | ||
| C07K 16/32 | (2006.01) | ||
| C07K 16/2851 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K2317/24 | (2013.01) | ||
| A61K 38/17 | (2006.01) | ||
| C07K2317/31 | (2013.01) | ||
| C07K 14/705 | (2006.01) | ||
| C07K2317/35 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2317/622 | (2013.01) | ||
| C07K2317/64 | (2013.01) | ||
| C07K2317/73 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K2317/94 | (2013.01) | ||
| C07K 16/2803 | (2013.01) | ||
| C07K 16/32 | (2013.01) | ||
| C07K2317/52 | (2013.01) | ||
| C07K2317/732 | (2013.01) | ||
| A61K 38/00 | (2013.01) | ||
| C07K 14/7056 | (2013.01) | ||
| C07K2317/70 | (2013.01) | ||
| C07K2317/565 | (2013.01) | ||
| C07K2317/92 | (2013.01) |
| (11) | Patento numeris | 3749346 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19750602.5 |
| Europos patento paraiškos padavimo data | 2019-02-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-12-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-07-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2019/017330 |
| Data | 2019-02-08 |
| (87) | Numeris | WO 2019/157366 |
| Data | 2019-08-15 |
| (30) | Numeris | Data | Šalis |
| 201862628161 P | 2018-02-08 | US | |
| 201862716259 P | 2018-08-08 | US |
| (72) |
CHANG, Gregory, P. , US
CHEUNG, Ann, F. , US
GRINBERG, Asya , US
HANEY, William , US
LUNDE, Bradley, M. , US
PRINZ, Bianka , US
FALLON, Daniel , US
WEI, Ronnie , US
O'NEIL, Steven , US
|
| (73) |
Dragonfly Therapeutics, Inc. ,
180 3rd Avenue, Sixth Floor, Waltham, MA 02451,
US
|
| (54) | ANTIBODY VARIABLE DOMAIN COMBINATIONS TARGETING THE NKG2D RECEPTOR |
| ANTIBODY VARIABLE DOMAIN COMBINATIONS TARGETING THE NKG2D RECEPTOR |